AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research ...
Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...
A new review reveals how focal adhesion kinase (FAK) acts as a central regulator of tumor progression and immune suppression ...
The tumor microbiota—which includes bacteria, fungi, viruses, and other microorganisms present in tumor tissue—is now ...
Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can be ...
Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...
Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...
Breast cancer is the most common form of cancer in women. According to the World Health Organization, in 2022, around 2.3 ...
The Hearty Soul on MSN
Scientists find antioxidant may feed tumor growth
Questions about antioxidants and cancer rarely stay simple. Antioxidants are usually framed as protective substances that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results